UBS Group’s Revolution Medicines RVMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$427M Buy
4,386,791
+1,298,854
+42% +$131M 0.08% 308
2025
Q4
$246M Buy
3,087,937
+1,998,972
+184% +$131M 0.05% 478
2025
Q3
$50.9M Buy
1,088,965
+574,212
+112% +$22.5M 0.01% 1608
2025
Q2
$18.9M Buy
514,753
+32,646
+7% +$1.25M ﹤0.01% 2414
2025
Q1
$17M Buy
482,107
+182,324
+61% +$7.4M ﹤0.01% 2509
2024
Q4
$13.1M Buy
299,783
+106,704
+55% +$5.38M ﹤0.01% 2774
2024
Q3
$8.76M Sell
193,079
-24,684
-11% -$1.07M ﹤0.01% 2496
2024
Q2
$8.45M Sell
217,763
-87,216
-29% -$3.26M ﹤0.01% 2364
2024
Q1
$9.83M Sell
304,979
-1,579
-0.5% -$46.8K ﹤0.01% 2289
2023
Q4
$8.79M Buy
306,558
+209,399
+216% +$5.03M ﹤0.01% 2210
2023
Q3
$2.69M Sell
97,159
-39,295
-29% -$1.17M ﹤0.01% 3159
2023
Q2
$3.65M Sell
136,454
-1,907
-1% -$46.8K ﹤0.01% 2892
2023
Q1
$3M Sell
138,361
-29,282
-17% -$721K ﹤0.01% 3006
2022
Q4
$3.99M Buy
167,643
+134,940
+413% +$2.87M ﹤0.01% 2715
2022
Q3
$645K Sell
32,703
-8,329
-20% -$183K ﹤0.01% 4121
2022
Q2
$800K Sell
41,032
-49,117
-54% -$956K ﹤0.01% 3906
2022
Q1
$2.3M Sell
90,149
-24,271
-21% -$528K ﹤0.01% 3306
2021
Q4
$2.88M Sell
114,420
-2,930
-2% -$82.6K ﹤0.01% 3402
2021
Q3
$3.23M Buy
117,350
+116,252
+10,588% +$3.38M ﹤0.01% 3139
2021
Q2
$35K Sell
1,098
-340
-24% -$11.9K ﹤0.01% 6775
2021
Q1
$66K Buy
1,438
+235
+20% +$10.5K ﹤0.01% 6284
2020
Q4
$48K Buy
+1,203
New +$47.6K ﹤0.01% 6227
2020
Q3
Sell
-4,892
Closed -$154K 8351
2020
Q2
$154K Sell
4,892
-3,479
-42% -$109K ﹤0.01% 4995
2020
Q1
$183K Buy
+8,371
New +$232K ﹤0.01% 4789

Other funds holding RVMD